Publication | Open Access
Safely Administering Potential QTc Prolonging Therapy Across a Large Health Care System in the COVID-19 Era
17
Citations
11
References
2020
Year
The risk of torsade de pointes is low in hospitalized patients with COVID-19 receiving hydroxychloroquine±azithromycin therapy.
| Year | Citations | |
|---|---|---|
Page 1
Page 1